Page last updated: 2024-08-16

technetium tc 99m sestamibi and atl 146e

technetium tc 99m sestamibi has been researched along with atl 146e in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beller, GA; Glover, DK; Linden, J; Macdonald, TL; Petruzella, FD; Rieger, JM; Riou, LM; Ruiz, M; Takehana, K; Watson, DD	1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and atl 146e

Article	Year
Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation, 2001, Sep-04, Volume: 104, Issue:10 Topics: Adenosine; Animals; Binding, Competitive; Blood Pressure; Cell Line; Coronary Disease; Cyclohexanecarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Humans; Infusions, Intravenous; Myocardium; Purinergic P1 Receptor Agonists; Purines; Radioligand Assay; Radionuclide Imaging; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Recombinant Proteins; Regional Blood Flow; Technetium Tc 99m Sestamibi	2001

Article

Year

Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.

Circulation, 2001, Sep-04, Volume: 104, Issue:10

Topics: Adenosine; Animals; Binding, Competitive; Blood Pressure; Cell Line; Coronary Disease; Cyclohexanecarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Humans; Infusions, Intravenous; Myocardium; Purinergic P1 Receptor Agonists; Purines; Radioligand Assay; Radionuclide Imaging; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Recombinant Proteins; Regional Blood Flow; Technetium Tc 99m Sestamibi

2001